BioHarvest Sciences Inc. (NASDAQ:BHST - Get Free Report) shares shot up 3% during mid-day trading on Tuesday . The company traded as high as $6.12 and last traded at $6.12. 12,484 shares changed hands during mid-day trading, an increase of 63% from the average session volume of 7,662 shares. The stock had previously closed at $5.94.
Wall Street Analyst Weigh In
BHST has been the subject of several research analyst reports. Maxim Group initiated coverage on BioHarvest Sciences in a research note on Wednesday, December 18th. They set a "buy" rating and a $12.00 target price for the company. HC Wainwright assumed coverage on shares of BioHarvest Sciences in a research note on Friday, December 6th. They set a "buy" rating and a $14.00 price objective on the stock.
View Our Latest Report on BHST
BioHarvest Sciences Stock Down 2.8 %
The stock has a market capitalization of $102.00 million, a price-to-earnings ratio of -4.97 and a beta of 2.27. The company's 50-day moving average is $5.58.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in BioHarvest Sciences stock. TD Waterhouse Canada Inc. bought a new position in BioHarvest Sciences Inc. (NASDAQ:BHST - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 12,042 shares of the company's stock, valued at approximately $69,000. TD Waterhouse Canada Inc. owned about 0.07% of BioHarvest Sciences as of its most recent SEC filing.
BioHarvest Sciences Company Profile
(
Get Free Report)
BioHarvest Sciences Inc is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications.
Featured Stories
Before you consider BioHarvest Sciences, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BioHarvest Sciences wasn't on the list.
While BioHarvest Sciences currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
